✦ LIBER ✦

Ovarian suppression plus tamoxifen (TAM) versus chemotherapy (CT) in patients with early breast cancer: Results of a meta-analysis of three adjuvant trials

✍ Scribed by F. Boccardo; R. Jakesz; H. Roché; A. Rubagotti; K. Thomanek; P. Kerbrat

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-4 Ovarian suppression (OS) and tamoxif

✍ F. Boccardo; A. Rubagotti; P. Guglielmini; D. Mesiti; A. Durando; A. Bolognesi; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Tamoxifen(TMX) vs. chemotherapy(CT) vs.

✍ P. Sismondi; F. Boccardo; P. Bruzzi; M. Cappellini; G. Isola; I. Nenci; A. Piffa 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Surgery versus tamoxifen in selected eld

✍ Cannon, P.M.; Low, S.C.; Dixon, A.; Ellis, I.O.; Elston, C.W.; Blamey, R.W. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 150 KB

2050 POSTER Endocrine effects of adjuvan

✍ E. Rossi; F. Perrone; G. Esposito; G. Landi; F. Di Rella; R. Thomas; C. Gallo; K 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Chemotherapy versus tamoxifen versus che

✍ Francesco Boccardo; Pamela Guglielmini; Andrea Parodi; Alessandra Rubagotti 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 535 KB

Postoperative adjuvant chemotherapy foll

✍ R Paridaens; J Dyczka; E.J.T Rutgers; R Coleman; T Cufer; J Jassem; J.W.R Nortie 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB